BSP Pharmaceuticals – ADC Review ADC Review #global #pharmaceutical #market

Posted On Nov 18 2017 by

#bsp pharma # Adding an inhibitor of ATP-binding cassette (ABC) transporters to sacituzumab govitecan increased the median survival of mice bearing a SN-38-resistant human gastric cancer cell line. Results from this precli. The U.S. Food and Drug Administration (FDA) has a granted Rare Pediatric Disease Designation for AbbVie’s ABT-414, an investigational antibody-drug conjugate (ADC) targeting the epidermal growth factor recept. BSP Pharmaceuticals Published on 27th October BSP Pharmaceuticals. a contract manufacturing organization (CMO) based in Italy, offers a range of dedicated services designed for pharmaceutical industry players focused on antineoplastic products. The company offers customized one-stop shop service to support …


Generic pharmaceuticals and competition #nutra #pharma

Posted On Nov 16 2017 by

#generic pharmaceutical # Competition Generic pharmaceuticals and competition Entry by generic pharmaceuticals can enhance competition in the drug market by offering more choice and by lowering drug prices to the benefit of health customers. At the same time, innovation in the pharmaceutical sector should be sustained, notably by allowing innovators to obtain intellectual property rights on their originator drug. Competition concerns arise, however, when originator companies use their intellectual property rights to delay or to prevent generic entry. Some pharmaceutical companies are using new potentially anticompetitive strategies. In June 2014 meeting, the OECD Competition Committee addressed recent developments regarding such …


New pharmaceuticals #best #pharma #companies

Posted On Nov 16 2017 by

#new pharmaceuticals # Athenex Announces the Addition of James Hussey to Lead its Commercial Business Activities Athenex announced today that James Hussey has joined the Company as Executive Vice President of Athenex Pharmaceutical Division. In this capacity, Mr. Hussey will be responsible for the execution of the commercial aspects of this business unit including strategy, new products, manufacturing, distribution, sales and marketing. Governor Cuomo Announces Major Expansion of Athenex Creating 1,400 Jobs in Western New York Athenex (formerly Kinex) to invest $1.62 billion in drug discovery and advanced manufacturing partnership, creating 900 jobs in Dunkirk and 500 jobs in Buffalo …


Novartis Pharmaceuticals #pharmaceutical #companies #india

Posted On Nov 16 2017 by

#novartis pharma # • Promotions for Women into Management: 37.8% higher than the Top 10 and 52.2% higher than the Top 50 • Supplier Diversity: Double the Top 10 average and triple the Top 50 average on subcontractors who are minority owned • SupplierDiversity: Four times higher than the Top10 average and nine times higher than the Top 50 average of subcontractors who are women owned Novartis Pharmaceuticals Corporation (NPC) continues to maintain an impressive track record on the Top 50 list, and the company is well known for its proven commitment to promoting women into management positions. D I …


Our Services to the Pharmaceuticals and Life Sciences Industry, PwC Canada #pharma #marketing #strategies

Posted On Nov 16 2017 by

#pharmaceutical companies in canada # Pharmaceuticals and Life Sciences Helping the business of health by improving the health of business Is it any surprise that Canada’s life sciences and pharmaceutical industry receives one out of every four dollars of venture capital investment? After all, an aging Canadian population has significantly increased demand for health-related products and treatment, and the sector is working hard to keep up. With the global pharmaceutical market predicted to double to $1.8 trillion by 2020, there is a lot at stake for Canadian players in this sector. Yet there are unique challenges facing our life sciences …


Social Media In The Pharmaceutical Industry: Pharmaceuticals: UK #pharma #blog

Posted On Nov 15 2017 by

#pharma social media # WHAT IS CPD? CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is: ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’ CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities. Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld. …


Mylan Pharmaceuticals Inc #pharma #sales #jobs

Posted On Nov 15 2017 by

#mylan pharma # Mylan Pharmaceuticals Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? …


Here s Why Raptor Pharmaceuticals Corp #biotechnology #industry

Posted On Nov 15 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 Other OTC: ELTP #ono #pharma

Posted On Nov 15 2017 by

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …


Qualitest Pharmaceuticals Company Information #cipla #pharma

Posted On Nov 15 2017 by

#drug manufacturer # Qualitest Pharmaceuticals Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? Drugs.com …